Cargando…
Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus
BACKGROUND: Patients in refractory status epilepticus (RSE) may require treatment with continuous intravenous anesthetic drugs (cIVADs) for seizure control. The use of cIVADs, however, was recently associated with poor outcome in status epilepticus (SE), raising the question of whether cIVAD therapy...
Autores principales: | Madžar, Dominik, Reindl, Caroline, Giede-Jeppe, Antje, Bobinger, Tobias, Sprügel, Maximilian I., Knappe, Ruben U., Hamer, Hajo M., Huttner, Hagen B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249897/ https://www.ncbi.nlm.nih.gov/pubmed/30463604 http://dx.doi.org/10.1186/s13054-018-2235-2 |
Ejemplares similares
-
Effects of clobazam for treatment of refractory status epilepticus
por: Madžar, Dominik, et al.
Publicado: (2016) -
Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury
por: Rühl, Lena, et al.
Publicado: (2022) -
Automated Pupillometry Identifies Absence of Intracranial Pressure Elevation in Intracerebral Hemorrhage Patients
por: Giede-Jeppe, Antje, et al.
Publicado: (2020) -
Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus
por: Reznik, Michael E., et al.
Publicado: (2016) -
Quantitative EEG may predict weaning failure in ventilated patients on the neurological intensive care unit
por: Welte, Tamara M., et al.
Publicado: (2022)